FDA Panel to Make Recommendation on Avandia

By: Ashton King Email
By: Ashton King Email

An FDA panel is expected to decide Wednesday if the diabetes drug Avandia should stay on the market.

Government experts are trying to determine if the once popular drug can increase the risk of heart attack.

The panel could recommend putting more warning labels on Avandia or pulling it.

The FDA usually follows recommendations from the advisory committee.

You must be logged in to post comments.

Password (case sensitive):
Remember Me:
WTVY-TV 285 N Foster Street Dothan, AL 36303 334-792-3195
Copyright © 2002-2016 - Designed by Gray Digital Media - Powered by Clickability 98396999 - wtvy.com/a?a=98396999
Gray Television, Inc.